The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

Completed

Phase 1 Results N/A

Summary of Purpose

Double blind, randomized, placebo control, multiple dose, dose escalation study

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 June 2016.

1 Mar 2015 12 Mar 2015 1 Aug 2015 1 Aug 2015 1 Mar 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Pharmacokinetics/Dynamics Study
  • Intervention: Parallel Assignment

Contacts